Scimega competitorsClear all

Scimega's top competitors include Innate Pharma, Gamida Cell, VECT-HORUS and OncoDNA.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Scimega
Scimega
Scimega is a provider of oncology clinical trial services.
Innate Pharma
Innate Pharma
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
Gamida Cell
Gamida Cell
Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases.
VECT-HORUS
VECT-HORUS
VECT-HORUS is a biotech company that develops peptide-based vectors to facilitate the delivery of drugs or imaging agents into the brain and to tumors.
OncoDNA
OncoDNA
OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients.
Founding Date
Founding Date
1997
Founding Date
1999
Founding Date
1998
Founding Date
2005
Founding Date
2012
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Laval, CA HQ
Locations
Marseille, FR HQ
Rockville, US
Locations
Boston, US HQ
Jerusalem, IL
Locations
Marseille, FR HQ
Locations
Charleroi, BE HQ
Employees
Employees
1917% decrease
Employees
2151% increase
Employees
52
Employees
34
Employees
632% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
219.4 m
Valuation ($)
105 m
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
1.2 k
Twitter followers
4 k
Twitter followers
N/A
Twitter followers
288
Twitter followers
654
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
24
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
556620
Alexa Website Rank
N/A
Alexa Website Rank
348251
Alexa Website Rank
N/A
Alexa Website Rank
174786
Employee Rating
Employee Rating
N/A
Employee Rating
4.1
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4.3

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 14.5m (over 1 year ago)
Latest funding round
$ 20.6m (over 2 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 94.1m
Total funding raised
$ 128.3m
Total funding raised
$ 29.4m
Total funding raised
$ 29.8m
For sources of this data, please see the company profile

View company profiles

Innate Pharma
HQ
Marseille, FR
Employees
215↑ 1% increase

Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.

View company
Gamida Cell
HQ
Boston, US
Employees
52

Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases.

View company
VECT-HORUS
HQ
Marseille, FR
Employees
34

VECT-HORUS is a biotech company that develops peptide-based vectors to facilitate the delivery of drugs or imaging agents into the brain and to tumors.

View company
OncoDNA
HQ
Charleroi, BE
Employees
63↑ 2% increase

OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients.

View company